These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10506648)

  • 1. Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines.
    Jabbal-Gill I; Lin W; Jenkins P; Watts P; Jimenez M; Illum L; Davis SS; Wood JM; Major D; Minor PD; Li X; Lavelle EC; Coombes AG
    Vaccine; 1999 Sep; 18(3-4):238-50. PubMed ID: 10506648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric lamellar substrate particles for intranasal vaccination.
    Jabbal-Gill I; Lin W; Kistner O; Davis SS; Illum L
    Adv Drug Deliv Rev; 2001 Sep; 51(1-3):97-111. PubMed ID: 11516782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sufficiency of a single administration of filarial antigens adsorbed on polymeric lamellar substrate particles of poly (L-lactide) for immunization.
    Saini V; Verma SK; Sahoo MK; Kohli DV; Murthy PK
    Int J Pharm; 2011 Nov; 420(1):101-10. PubMed ID: 21855618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable poly-l-lactide based microparticles as controlled release delivery system for filarial vaccine candidate antigens.
    Anugraha G; Madhumathi J; Jeya Prita PJ; Kaliraj P
    Eur J Pharmacol; 2015 Jan; 747():174-80. PubMed ID: 25514604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric lamellar substrate particles as carrier adjuvant for recombinant hepatitis B surface antigen vaccine.
    Saini V; Sahoo MK; Murthy PK; Kohli D
    Vaccine; 2009 Apr; 27(17):2372-8. PubMed ID: 19428853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
    Gupta RK; Chang AC; Siber GR
    Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of alum in improving the immunogenicity of biodegradable polymer particle entrapped antigens.
    Kanchan V; Katare YK; Panda AK
    Eur J Pharm Sci; 2009 Aug; 38(1):18-28. PubMed ID: 19467323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable lamellar particles of poly(lactide) induce sustained immune responses to a single dose of adsorbed protein.
    Coombes AG; Lavelle EC; Davis SS
    Vaccine; 1999 May; 17(19):2410-22. PubMed ID: 10392623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines.
    Coombes AG; Major D; Wood JM; Hockley DJ; Minor PD; Davis SS
    Biomaterials; 1998 Jun; 19(11-12):1073-81. PubMed ID: 9692806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopotentiation of hepatitis B vaccine using biodegradable polymers as an adjuvant.
    Sivakumar SM; Sukumaran N; Nirmala L; Swarnalakshmi R; Anilbabu B; Siva L; Anbu J; Shanmugarajan TS; Ravichandran V
    J Microbiol Immunol Infect; 2010 Aug; 43(4):265-70. PubMed ID: 20688285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs.
    Johansen P; Moon L; Tamber H; Merkle HP; Gander B; Sesardic D
    Vaccine; 1999 Sep; 18(3-4):209-15. PubMed ID: 10506644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
    Jiang W; Gupta RK; Deshpande MC; Schwendeman SP
    Adv Drug Deliv Rev; 2005 Jan; 57(3):391-410. PubMed ID: 15560948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant.
    Jain S; O'Hagan DT; Singh M
    Expert Rev Vaccines; 2011 Dec; 10(12):1731-42. PubMed ID: 22085176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in vaccine adjuvants for systemic and mucosal administration.
    O'Hagan DT
    J Pharm Pharmacol; 1998 Jan; 50(1):1-10. PubMed ID: 9504429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved immunogenicity of biodegradable polymer particles entrapped rotavirus vaccine.
    Nayak B; Ray AR; Panda AK; Ray P
    J Biomater Appl; 2011 Jan; 25(5):469-96. PubMed ID: 20207774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters.
    Felder ChB; Blanco-Príeto MJ; Heizmann J; Merkle HP; Gander B
    J Microencapsul; 2003; 20(5):553-67. PubMed ID: 12909541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
    Mohanan D; Gander B; Kündig TM; Johansen P
    Eur J Pharm Biopharm; 2012 Feb; 80(2):274-81. PubMed ID: 22024408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soybean agglutinin coated PLA particles entrapping candidate vaccines induces enhanced primary and sustained secondary antibody response from single point immunization.
    Gupta RK; Goswami DG; Singh RR; Surolia A; Panda AK
    Eur J Pharm Sci; 2012 Feb; 45(3):282-95. PubMed ID: 22155747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent.
    Young TJ; Johnston KP; Mishima K; Tanaka H
    J Pharm Sci; 1999 Jun; 88(6):640-50. PubMed ID: 10350502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.